Table 2. Comparison of Uptake of COVID-19 Primary Outcomes Between the Matched MDPCP Group and Nonparticipating Group.
Measure | Participant groupa | P value | |
---|---|---|---|
MDPCP (n = 208 146) | Nonparticipating (n = 37 203) | ||
Vaccine status | |||
Not vaccinated | 27 328 (13.13) | 6926 (18.62) | <.001 |
Fully vaccinated | |||
With booster | 136 958 (65.80) | 21 768 (58.51) | |
Without booster | 38 855 (18.67) | 7225 (19.42) | |
Partially vaccinated | 5005 (2.40) | 1284 (3.45) | |
Booster vaccine status | |||
No | 71 188 (34.20) | 15 435 (41.49) | <.001 |
Yes | 136 958 (65.80) | 21 768 (58.51) | |
COVID-19–positive beneficiaries | |||
With monoclonal antibody infusionb | 1152 (8.45) | 161 (6.11) | <.001 |
With telehealth service claimsb | 8579 (62.95) | 1438 (54.53) | <.001 |
Abbreviation: MDPCP, Maryland Primary Care Program.
Unless otherwise indicated, data are expressed as No. (%) of participants. Percentages have been rounded and therefore may not sum to 100.
Includes 13 628 in the MDPCP group and 2673 in the nonparticipating group.